Moderna
MRNA
#1162
Rank
HK$151.57 B
Marketcap
HK$382.21
Share price
-0.87%
Change (1 day)
91.89%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -HK$21.52 Billion

According to Moderna 's latest financial reports the company's current earnings are HK$1.92 Billion. , an increase over its 2024 earnings that were of -HK$28.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -HK$21.62 Billion-23.03%
2024 -HK$28.08 Billion-8.22%
2023 -HK$30.6 Billion-140.65%
2022 HK$75.26 B-27.81%
2021 HK$104.25 B-1911.15%
2020 -HK$5.76 Billion44.7%
2019 -HK$3.98 Billion28.63%
2018 -HK$3.1 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.94 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.14 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$175.72 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-HK$0.38 Billion-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.93 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.33 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$4.51 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$2.70 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA